Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Enhancing Cognitive and Postoperative Recovery After Cardiac Surgery in Older Adults (ECPON II) (ECPON II)

13 de novembro de 2026 atualizado por: Ulrica Nilsson, Karolinska Institutet

Enhancing Cognitive Function and POstoperative Neurocognitive Recovery After Cardiac Surgery in Older Adults

Postoperative cognitive complaints are common among older adults undergoing cardiac surgery and may negatively affect recovery, daily functioning, independence, and quality of life. The ECPON II study evaluates the effectiveness of a co-designed, nurse navigator-led intervention designed to support cognitive and postoperative recovery in older adults undergoing cardiac surgery.

Fifty patients aged 65 years or older undergoing cardiac surgery will receive the intervention. Outcomes will be compared with data from 150 matched historical controls from the previous ECPON observational study (ECPON I; NCT06469515). The historical controls are not enrolled in ECPON II.

The intervention consists of four coordinated components: information and education, postoperative consultations, cognitive assessments, and peer support, coordinated and delivered by a nurse navigator. The primary outcome is patient-reported cognitive complaints. Secondary outcomes include postoperative recovery, cognitive function, delirium, frailty, depression, health-related quality of life, functional capacity, self-efficacy, caregiver burden, and cost-utility. Participants will be followed for six months after surgery.

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Intervenção / Tratamento

Descrição detalhada

Postoperative neurocognitive impairment and cognitive complaints are important complications following cardiac surgery in older adults. Cognitive complaints may include difficulties with memory and concentration, fatigue, sleep disturbances, and reduced ability to manage everyday activities. These problems may influence postoperative recovery, independence, rehabilitation, and quality of life and may also affect close relatives.

ECPON II is a quasi-experimental superiority study evaluating a co-designed intervention coordinated and delivered by a nurse navigator. The intervention was developed through an experience-based co-design process involving older adults who had undergone surgery, close relatives, healthcare professionals, and scientific experts.

The intervention comprises four core components: (1) information and education regarding postoperative cognitive difficulties and strategies for managing them; (2) individualized postoperative consultations with a nurse navigator; (3) cognitive assessments before and after surgery to identify and follow cognitive difficulties and support individualized postoperative care; and (4) peer-support sessions for patients and close relatives.

Fifty patients aged 65 years or older undergoing open cardiac surgery will be prospectively enrolled and receive the intervention. Each patient will be asked to nominate a close relative who will be invited to participate in selected study activities. Close relatives will provide assessments of the patient's cognitive functioning and caregiver burden and may participate in peer-support sessions and qualitative interviews. If the patient has no close relative or the nominated person declines participation, the patient remains eligible for the study.

Outcomes in the intervention group will be compared with data from 150 matched historical controls from ECPON I (NCT06469515), an observational study conducted in the same patient population. The historical controls are used as comparator data and are not included in the ECPON II enrollment.

The primary objective is to determine whether the intervention reduces patient-reported cognitive complaints following cardiac surgery. Secondary objectives include evaluating postoperative recovery, cognitive function, self-efficacy, functional status, fatigue, depression, frailty, health-related quality of life, caregiver burden, and cost-utility.

A purposive sample of approximately 20-40 patients and their close relatives will participate in semi-structured individual interviews six months after surgery to explore experiences of the intervention, mechanisms of impact, feasibility, postoperative cognition, and recovery. In addition, all patients will be asked about any experience with postoperative delirium and, if so, to describe any long-term experiences as well as overall experience of postoperative cognition and its impact on recovery.

Tipo de estudo

Intervencional

Inscrição (Estimado)

50

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

  • Nome: Lina Bergman, PhD
  • Número de telefone: 0046 33 435 44 11
  • E-mail: lina.bergman@hb.se

Locais de estudo

      • Gothenburg, Suécia
        • Sahlgrenska University Hospital, Gothenburg
        • Contato:
          • Tor Damén, MD, PhD

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

65 anos e mais velhos (Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Scheduled for elective or urgent open-heart surgery or minimally invasive cardiac surgery
  • Resident in the area/region for the current thoracic clinic
  • Able to read and understand Swedish

Exclusion Criteria:

  • Physical, mental, and cognitive difficulties that prevent the individual from completing the cognitive tests
  • Undergone surgery within the last 6 months

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: ECPON II Nurse Navigator-led Intervention

The intervention comprises four coordinated components:

  1. Information and education: Verbal and written information about cognitive difficulties after cardiac surgery, their impact on daily life and recovery, and strategies for managing them.
  2. Postoperative consultations: An individual consultation with the nurse navigator 2-3 weeks after discharge, addressing recovery, challenges, support, and self-management. A person-centred care plan is developed, with additional consultations as needed.
  3. Cognitive assessment: Cognitive function, cognitive complaints, daily functioning, and recovery are assessed before and after surgery to guide individualized support.
  4. Peer support: Small-group sessions for patients and close relatives, facilitated by the nurse navigator, focus on shared experiences, self-management, and recovery.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Patient-reported cognitive complaints
Prazo: Preoperatively and weekly from 3-5 days after discharge through 6 months after surgery.

Patient-reported cognitive complaints will be assessed using the Cognitive Recovery dimension of the Swedish Quality of Recovery-Cognitive (SwQoR-Cog). The dimension comprises 10 items assessing symptoms related to cognitive complaints, including fatigue, sleep difficulties, concentration difficulties, frustration, forgetfulness, difficulties reading or calculating, and reduced ability to function independently. Each symptom is rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time"), with higher scores indicating a greater symptom burden.

Preoperatively and weekly from 3-5 days after discharge through 6 months after surgery.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Postoperative recovery
Prazo: Preoperatively and weekly through 6 months

Evaluated with the General recovery dimension of the SwQoR-Cog, consisting of 4 items measuring symptoms related to pain, nausea, the wound, and difficulties with personal hygiene. Each item is rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time"), with higher scores indicating a greater symptom burden.

Preoperatively and weekly through 6 months
Nightmares
Prazo: Weekly through 6 months

Patient-reported frequency/severity of nightmares rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time").

Weekly through 6 months
Cognitive function
Prazo: Preoperatively, 1 month, 3 months and 6 months

Consortium to Establish a Registry for Alzheimer's Disease (CERAD). The CERAD measures verbal learning and memory performance. Participants are presented with a list of 10 words across three learning trials and asked to recall as many words as possible after each trail.

Preoperatively, 1 month, 3 months and 6 months
Executive functioning
Prazo: Preoperatively, 1 month, 3 months and 6 months

Stroop Colour-Word Interference Test (SCWT) is used to assess executive functioning, selective attention, and inhibitory control. In this timed test, participants are required to identify the colour of words printed in incongruent colours as quickly and accurately as possible

Preoperatively, 1 month, 3 months and 6 months
Postoperative delirium
Prazo: Three times daily during hospitalization

Nursing Delirium Screening Scale (Nu-DESC). The scale assesses five symptom domains associated with delirium, with higher scores reflecting greater symptom severity. A total score of 2 or above is considered indicative of delirium.

Three times daily during hospitalization
Frailty
Prazo: Preoperatively and 6 months

Clinical Frailty Scale (CFS), a nine-point instrument that classifies individuals from very fit to terminally ill. Assessments are conducted by trained clinicians based on the individual's pre-illness functional status.

Preoperatively and 6 months
Depressive symptoms
Prazo: Preoperatively, 1 month, 3 months and 6 months

Patient Health Questionnaire-9 (PHQ-9), nine items assessing depressive symptoms experienced during the preceding two weeks, with response options ranging from 0 ("not at all") to 3 ("nearly every day").

Preoperatively, 1 month, 3 months and 6 months
Health-related quality of life
Prazo: Preoperatively and 6 months

RAND-36 questionnaire encompassing eight dimensions of health: physical functioning, physical role limitations, emotional role limitations, vitality, mental health, social functioning, pain, and general health. Domain scores as well as physical and mental summary scores will be calculated to provide an overall assessment of health status.

Preoperatively and 6 months
Functional capacity
Prazo: Preoperatively, 1 month, 3 months and 6 months

World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0), 12-item version. This instrument evaluates difficulties in performing everyday activities and participating in daily life in relation to an individual's current health status. Each item is rated on a five-point scale reflecting the degree of difficulty experienced, generating a total score ranging from 0 to 48. Higher scores indicate greater disability and functional limitations

Preoperatively, 1 month, 3 months and 6 months
Self-efficacy
Prazo: Preoperatively, 1 month, 3 months and 6 months

General Self-Efficacy Scale (GSE), 10 items assessing an individual's perceived ability to handle demanding situations and solve problems effectively. Items are rated on a four-point scale, and higher scores reflect greater self-efficacy.

Preoperatively, 1 month, 3 months and 6 months
Cognitive functioning assessed by close relatives
Prazo: Preoperatively, 1 month, 3 months and 6 months

Cognitive Failures Questionnaire for Others (CFQ-f). The questionnaire contains eight items measuring observed cognitive difficulties in daily life, with responses provided on a five-point scale from never to always. The instrument has been translated and culturally adapted for Swedish use by our research group following back-translation procedures. The recall period was shortened from six months in the original version to one month to better reflect the postoperative recovery trajectory.

Preoperatively, 1 month, 3 months and 6 months
Caregiver burden
Prazo: Preoperatively, 1 month, 3 months and 6 months

Zarit Burden Interview, 12-item version (ZBI-12). The instrument contains 12 items, each rated on a five-point Likert scale ranging from never to nearly always.

Preoperatively, 1 month, 3 months and 6 months
Plasma osmolality
Prazo: Preoperatively and postoperative day 1

Osmolality will be estimated using the blood-based biomarkers sodium, glucose, and urea and calculated according to the following formula: Osmolarity (mOsm/L) = 2 × Sodium (mmol/L) + Glucose (mg/dL) / 18 + Urea (mg/dL) / 2.8.

Preoperatively and postoperative day 1
Cost-utility
Prazo: Through 6 months

Will be assessed by calculating quality-adjusted life years (QALYs) gained using data obtained from the RAND-36.

Through 6 months

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Demographic and perioperative data
Prazo: At baseline and perioperatively

Will be collected from the medical record.

At baseline and perioperatively

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de janeiro de 2027

Conclusão Primária (Estimado)

1 de dezembro de 2027

Conclusão do estudo (Estimado)

1 de dezembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

13 de novembro de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

13 de novembro de 2026

Primeira postagem (Real)

19 de novembro de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

19 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

13 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 2026-06328-01

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .